Browse > Article

Myeloperoxidase -463G>A Polymorphism dose not Contribute to the Risk of Primary Lung Cancer in a Korean Population  

Park, Jae Hyoung (Department of Internal Medicine, Kyungpook National University Hospital)
Park, Jung Min (Cancer Research Institute, School of Medicine, Kyungpook National University)
Kim, Eun Jin (Department of Internal Medicine, Kyungpook National University Hospital)
Yun, Suk Jin (Department of Internal Medicine, Kyungpook National University Hospital)
Lee, Sung Jun (Department of Internal Medicine, Kyungpook National University Hospital)
Cha, Sung Ick (Department of Internal Medicine, Kyungpook National University Hospital)
Lee, Eung Bae (Department of Thoracic Surgery, Kyungpook National University Hospital)
Kim, Chang Ho (Department of Internal Medicine, Kyungpook National University Hospital)
Kam, Sin (Department of Preventive Medicine, School of Medicine, Kyungpook National University)
Kim, Dong Sun (Department of Anatomy, School of Medicine, Kyungpook National University)
Jung, Tae Hoon (Department of Internal Medicine, Kyungpook National University Hospital)
Park, Jae Yong (Department of Internal Medicine, Kyungpook National University Hospital)
Publication Information
Tuberculosis and Respiratory Diseases / v.59, no.2, 2005 , pp. 157-163 More about this Journal
Keywords
Myeloperoxidase; Polymorphism; Lung cancer susceptibility;
Citations & Related Records

Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Mallet WG, Mosebrook DR, Trush MA. Activation of $({\pm})$-trans-7, 8-dihydroxy-7, 8-dihydrobenzo[a]pyrene to diolepoxides by human polymorphonuclear leukocytes or myeloperoxidases. Carcinogenesis 1991;12:521-4   DOI   ScienceOn
2 Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996;271:14412-20   DOI   ScienceOn
3 Dally H, Gassner K, Jager B, Schmezer P, Spiegelhalder B, Edler L, et al. Myeloperoxidase (MPO) genotype and lung cancer histologic types: the MPO-463 a allele is associated with reduced risk for small cell lung cancer in smokers. Int J Cancer 2002;102:530-5   DOI   ScienceOn
4 Lee GY, Jang JS, Lee SY, Jeon HS, Kim KM, Choi JE, et al. XPC polymorphisms and lung cancer risk. Int J Cancer 2005;15:807-13   DOI   ScienceOn
5 Schabath MB, Spitz MR, Hong WK, Delclos GL, Reynolds WF, Gunn GB, et al. A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer 2002;37:35-40   DOI   ScienceOn
6 Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, et al. The myeloperoxidase -463 G -> a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev 2002;11:1555-9
7 Chevrier I, Stucker I, Houllier AM, Cenee S, Beaune P, Laurent-Puig P, et al. Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenetics 2003;13:729-39   DOI   ScienceOn
8 Cascorbi I, Henning S, Brockmoller J, Gephart J, Meisel C, Miller JM, et al. Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant -463A of the myeloperoxidase gene. Cancer Res 2000;60:644-9
9 London SJ, Lehman TA, Taylor JA. Myeloperoxidase genetic polymorphism and lung cancer risk. Cancer Res 1997;57:5001-3
10 Misra RR, Tangrea JA, Virtamo J, Ratnasinghe D, Andersen MR, Barrett M, et al. Variation in the promoter region of the myeloperoxidase gene is not directly related to lung cancer risk among male smokers in Finland. Cancer Lett 2001;164:161-7   DOI   ScienceOn
11 Lee SJ, Lee SY, Jeon HS, Park SH, Jang JS, Lee GY, et al. Vascular endothelial growth factor gene polymorphisms and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2005;14:571-5   DOI   ScienceOn
12 Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, et al. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis 2004;26:403-9   DOI   ScienceOn
13 Hong YC, Lee KH, Yi CH, Ha EH, Christiani DC. Genetic susceptibility to term pregnant women to oxidative damage. Toxicol Lett 2002;129:255-62   DOI   ScienceOn
14 Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Tajima K, et al. Low expression myeloperoxidase genotype negatively associated with Helicobacter pylori infection. Jpn J Cancer Res 2001;92:488-93   DOI
15 le Marchand l, Seifried A, Lum A, Wilkens LR. Association of the myeloperoxidase -463 G -> a polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:181-4
16 Lu W, Xing D, Qi J, Tan W, Miao X, Lin D. Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population. Int J Cancer 2002;102:275-9   DOI   ScienceOn
17 Lee CT, Kang KH, Koh Y, Chang J, Chung HS, Park SK, et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer 2000;30:15-22   DOI   ScienceOn
18 Feyler A, Voho A, Bouchardy C, Kuokkanen K, Dayer P, Hiroven A, et al. Myeloperoxidase -463 G -> a polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2002;11:1550-4
19 van Schooten FJ, Boots AW, Knaapen AM, Godschalk RW, Maas LM, Borm PJ, et al. Myeloperoxidase (MPO) -463G->A reduces MPO activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol Biomarkers Prev 2004;13:828-33